FEI Tribunal issues Consent Awards in equine anti-doping case

Media updates
19 April 2022 Author: FEI

The FEI Tribunal has issued Consent Awards in an equine anti-doping case involving a Banned Substance.

In this case, the horse Basc Trio (FEI ID 106QW17/UAE), tested positive for the Banned Substance 5α-estrone-3β, 17α-diol (metabolite of Nandrolone), following samples taken at the CEI1*100 Dubai (UAE), 7-14 November 2021.

The athlete, Abdul Aziz Salah Abdulla Ameen (FEI ID 10063337/UAE) and the trainer, Amr Mohd Atris El Sayed (FEI ID 10054579/UAE), admitted the rule violation and accepted the consequences. In its final decisions, the FEI Tribunal disqualified the horse and athlete combination from the event and imposed an 18-month ineligibility period on the athlete and on the trainer; the provisional suspension each has already served shall be credited against the imposed ineligibility period. The athlete and trainer were also each fined CHF 5,000.

The Consent Awards are available here.

 

Separately, the FEI has announced a new adverse analytical finding (AAF) involving an equine prohibited substance. The case involves *Banned Substance under the FEI’s Equine Anti-Doping and Controlled Medication Regulations (EADCMRs).

In the following Endurance case, the athlete and the trainer have been provisionally suspended until the FEI Tribunal renders its decisions. The horse has been provisionally suspended for two months from the date of notification.

Case 2022/BS04:

Horse: Dactyle D’Aqui (106XH16/UAE)

Person Responsible: Muhammad Ali Fazal Amin (10103705/PAK (UAE)

Trainer: Ahmed Ali Salman Hassan Al Sabri (10041041/UAE)

Event: CEI2*120 – Bou Thib (UAE), 24-25.12.2021

Prohibited Substance(s): Testosterone

Date of notification: 8 March 2022

Details on these case can be found here.

Notes to Editors:

FEI Clean Sport - human athletes

The FEI is part of the collaborative worldwide movement for doping-free sport led by the World Anti-Doping Agency (WADA). The aim of this movement is to protect fair competition as well as athlete health and welfare.

WADA’s Prohibited List identifies the substances and methods prohibited in- and out-of-competition, and in particular sports. The substances and methods on the List are classified by different categories (e.g., steroids, stimulants, gene doping).

As a WADA Code Signatory, the FEI runs a testing programme for human athletes based on WADA’s List of Prohibited List of Substances and Methods and on the Code-compliant FEI Anti-Doping Rules for Human Athletes (ADRHA).

For further information, please consult the Clean Sport section of the FEI website here.

FEI Equine Prohibited Substances

The FEI Prohibited Substances List is divided into two sections: Controlled Medication and *Banned Substances. Controlled Medication substances are medications that are regularly used to treat horses, but which must have been cleared from the horse’s system by the time of competition. Banned (doping) Substances should never be found in the body of the horse and are prohibited at all times.

In the case of an adverse analytical finding (AAF) for a Banned Substance, the Person Responsible (PR) is automatically provisionally suspended from the date of notification (with the exception of certain cases involving a Prohibited Substance which is also a **Specified Substance). The horse is provisionally suspended for two months.

Information on all substances is available on the searchable FEI Equine Prohibited Substances Database.